Drugs / Decitabine/cedazuridine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06445959 | Aug 2024 → Jun 2027 expected | — | M.D. Anderson Cancer Center | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Decitabine/cedazuridine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06445959 ↗ |
| Route | Oral | “Given by PO” NCT06445959 ↗ |